Investor Relations
OSR Health, an Open and Socially Responsible Healthcare Group
Investor Relations
OSR Health, an Open and Socially Responsible Healthcare Group
OSR Health, Inc. (NASDAQ: OSRH) is a healthcare-focused holding company committed to building long-term shareholder value through strategic investment in immuno-oncology, regenerative biologics, and medical device technologies.
Latest Research
https://emerginggrowth.com/profile/osrh/
August 27, 2026: Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc.
July 2, 2026: Planning to Reward Long-Term Shareholders - We are bullish with a Buy-Emerging rating and $10.00 target.
March 26, 2026: 2nd Materially Positive Event in Recent Months - We remain bullish with a Buy-Emerging rating and a $10.00 price target.
December 4, 2025: New Licensing Deal is a BIG Deal - We remain bullish with a Buy-Emerging rating and a $10.00 price target (on watch for potential upgrade). December 4, 2025.
October 20, 2025: Future Focus - Initiate coverage with a Buy-Emerging rating with a $10.00 price target. October 20, 2025.
Latest News
OSR Health, Inc. (NASDAQ: OSRH) is a healthcare-focused holding company committed to building long-term shareholder value through strategic investment in immuno-oncology, regenerative biologics, and medical device technologies.
Latest Research
https://emerginggrowth.com/profile/osrh/
August 27, 2026: Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc.
July 2, 2026: Planning to Reward Long-Term Shareholders - We are bullish with a Buy-Emerging rating and $10.00 target.
May 5, 2026: Specialty-Financed Licensing Deal Delivers Strong De-Risking - We are bullish with a Buy-Emerging rating and $10.00 target.
March 26, 2026: 2nd Materially Positive Event in Recent Months - We remain bullish with a Buy-Emerging rating and a $10.00 price target.
December 4, 2025: New Licensing Deal is a BIG Deal - We remain bullish with a Buy-Emerging rating and a $10.00 price target (on watch for potential upgrade).
October 20, 2025: Future Focus - Initiate coverage with a Buy-Emerging rating with a $10.00 price target. October 20, 2025.
Latest News
OSR Health, Inc. Reg No. 589-86-01485
Email: ir@osr-health.com
US: 10900 NE 4th Street, 2300 Bellevue, WA 98004
KR: B-dong, 3F, 37-36 Hoedong-gil, Paju-si, Gyeonggi-do
CH: Technologiepark Basel, Hochbergerstrasse 60c
Copyright © OSR Health, Inc. All Rights Reserved.
BELLEVUE, Wash., Aug. 1, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that it will host a Virtual Investor Event on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time (2:00 p.m. Central European Summer Time / 9:00 p.m. Korea Standard Time).
The event will provide shareholders and prospective investors with a detailed update of the Company's strategic direction, subsidiary performance, capital allocation, and pipeline R&D. Senior members of the OSRH executive team will be presenting.
Event Details
Date: Wednesday, August 6, 2025
Time: 8:00 a.m. ET / 2:00 p.m. CEST / 9:00 p.m. KST
Location: Virtual (livestream access)
Registration: Opens Monday, August 4 at www.osr-holdings.com/events
Replay: Available after the event on the OSR Holdings Investor Relations website.
Agenda Highlights
"This event is a timely opportunity to engage with our shareholders and the broader investment community as we move into a transformative stage in OSR's growth," said Peter Hwang, CEO of OSRH. "We look forward to showcasing the strength of our platform, the progress we've made, and the catalysts ahead. We are committed to transparency, disciplined execution, and delivering meaningful value to all stakeholders in the coming months."
Featured Speakers:
About OSR Holdings, Inc.
OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno‑oncology, regenerative biologics, and medical device distribution. OSRH's vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting‑edge research and development. For more information, visit www.OSR‑Holdings.com.
SOURCE OSR Holdings